跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Evrysdi - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Evrysdi
Approved
STANDARD
Evrysdi
F. Hoffmann-La Roche, Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1b1cdf5e246bc444
Company
F. Hoffmann-La Roche, Ltd.
Type
Standard
Approval Details
Approval Id
1b1cdf5e246bc444
Drug Approval Philippines Name
Evrysdi
Product Name
Evrysdi
Registration Number
DR-XY47967
Brand Name
Evrysdi
Generic Name
Risdiplam
Dosage Form
Powder For Oral Solution
Dosage Strength
0.75 mg/mL
Manufacturer
F. Hoffmann-La Roche, Ltd.
Importer
Roche (Philippines), Inc
Distributor
Roche (Philippines), Inc
Company Detail Path
/organization/f-hoffmann-la-roche-ltd-switzerland
Issuance Date
26 April 2022
Expiry Date
26 April 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1b1cdf5e246bc444
Type
Standard
Back to Philippines FDA Approvals